MANUFACTURING
Facility
ECI’s manufacturing facility includes controlled areas for hormonal, high-potency/microdose and ODT products.
State-of-the-Art cGMP Manufacturing Facility:
- 65,000+ sq. ft. facility
- Site is FDA, DEA, and DOH/DBPRS compliant
- Manufacturing, QC lab, R&D manufacturing, R&D analytical testing, clinical packaging, warehouse
- Licenses (includes Schedules I-V)
— FDA registration (twice inspected and approved)
— DEA licenses (Manufacturing, Import, Export & Wholesale)
— State licenses (Manufacturing and Wholesale)
Manufacturing Facility
ECI’s manufacturing facility includes controlled areas for hormonal, high-potency/microdose and ODT products.
State-of-the-Art cGMP Manufacturing Facility:
- 20,000+ sq. ft. facility
- Site is FDA, DEA, and DOH/DBPRS compliant
- Manufacturing, QC lab, R&D manufacturing, R&D analytical testing, clinical packaging, warehouse
- Licenses (includes Schedules I-V)
— FDA registration (twice inspected and approved)
— DEA licenses (Manufacturing, Import, Export & Wholesale)
— State licenses (Manufacturing and Wholesale)
Capabilities
ECI Pharmaceuticals offers a broad range of U.S.-based manufacturing capabilities that allow for the processing of a variety of solid and liquid oral dosage forms.
- Tablets, capsules, powders, and oral solutions requiring degrees of high-shear granulation, fluid-bed processing, bi-layers, and film coating.
- Immediate release, extended release, hormone containment, cytotoxic containment, and ODT technology products.